Femto Medicine - Part 2601

Page 2,601«..10 20..2,6002,6012,602 2,603..2,610 2,620..»

Plastic fantastic: is surgery transforming some of Hollywood's best-known and best-loved faces?

Posted: Published on February 12th, 2015

And this in a town which has long considered womens physiognomy a pretty moveable feast. Yet theyre not alone. Look past Renee and Uma, and theres Courtney Cox, who seems to have acquired a more exaggerated and wider cheek bone. Heres Catherine Zeta Jones, who looks side on as though someone has popped a spare breast implant under each cheek. Scarlett Johansson, at a youthful 30, has even laid down a marker, saying: ''I definitely believe in plastic surgery. I dont want to be an old hag. Theres no fun in that. Crucially it doesnt seem enough to look ''refreshed, any more. Practitioners of the new approach seem to be adopting a design ethic that knows no aesthetic limits. Uma Thurman in Sweden three months ago (Rex) So whats driving it? One Hollywood insider tells me that women are on a desperate trajectory: ''Two things are forever on the rise out here: cosmetic science and female insecurity. Merge the two and you get the perfect storm were now witnessing, where stars seem to want to look like anyone but themselves - and are succeeding. The casting couch long ago went the way of multi-million dollar lawsuits, but in its place … Continue reading →

Posted in Aesthetic Surgery | Comments Off

University advances stem cell technologies amid political contention

Posted: Published on February 12th, 2015

Editors note: Upon request, some individuals interviewed for this article have been identified by first name only. _______________ The Statement is The Michigan Daily's weekly news magazine, distributed every Wednesday during the academic year. It is exciting for me to think that this tiny group of cells could be the seed to help people suffering with diseases in the future, Patricia said. In the Medical Science Building at the Universitys Medical School, I looked through a microscope at a 35-millimeter petri dish and saw microscopic organisms that could apparently one day provide treatments for a host of debilitating genetic diseases. These microscopic organisms are called human embryonic stem cell colonies. The room is the Universitys MStem Cell Laboratories, which develops human embryonic stem cell lines from disease-affected embryos. Last month The Michigan Daily reported on one such stem cell line developed from an embryo that had been donated by a University alumna. But as the University looks to grow such efforts, it remains unclear how the current political landscape might alter the path of such research. *** The difficulty in studying genetic diseases is observing how they begin and how they grow. Without access to the formation of the cells, … Continue reading →

Posted in Stem Cell Human Trials | Comments Off

TiGenix: TiGenix and Lonza sign agreement for the manufacture of stem cell-based treatment of complex perianal …

Posted: Published on February 12th, 2015

PRESS RELEASE TiGenix and Lonza sign agreement for the manufacture of stem cell-based treatment of complex perianal fistulas in Crohn's disease TiGenix's Cx601 product is currently in Phase 3 in Europe for the treatment of complex perianal fistulas in Crohn's disease Lonza to manufacture Cx601 product for TiGenix's Phase 3 trial in the US at Lonza's Walkersville, Maryland (US) facility Basel, Switzerland, and Leuven, Belgium, 12 February 2015 - Lonza, a global leader in biological and cell therapy manufacturing and TiGenix, an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from allogeneic expanded adipose-derived stem cells (eASCs) in inflammatory and autoimmune diseases, announced today an agreement for the supply of TiGenix's eASC product, Cx601. Under the agreement, Lonza will manufacture material for the Phase 3 trial of Cx601 in the US at Lonza's cell therapy production facility in Walkersville, Maryland (US). Cx601 is a locally-injected suspension of allogeneic expanded adipose-derived stem cells (eASCs) for the treatment of complex perianal fistulas in Crohn's disease patients, currently in Phase 3 of clinical development in Europe. Following the positive feedback received at a meeting with the Center for Biologics Evaluation and Research within the US Food and Drug Administration (FDA), TiGenix … Continue reading →

Comments Off